Matches in Wikidata for { <http://www.wikidata.org/entity/Q85300419> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q85300419 description "article scientifique publié en 2012" @default.
- Q85300419 description "artículu científicu espublizáu n'ochobre de 2012" @default.
- Q85300419 description "im Oktober 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85300419 description "scientific article published on 01 October 2012" @default.
- Q85300419 description "wetenschappelijk artikel" @default.
- Q85300419 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q85300419 name "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 name "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 type Item @default.
- Q85300419 label "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 label "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 prefLabel "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 prefLabel "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 P1433 Q85300419-D5D3127F-4840-4B27-A224-5019C373D4E6 @default.
- Q85300419 P1476 Q85300419-22EC69BD-E9C3-4847-81AC-039D5F2DA150 @default.
- Q85300419 P2093 Q85300419-219A03FA-F298-42F9-B6EE-5D1F38632120 @default.
- Q85300419 P2093 Q85300419-6D26B95A-8DEC-4E65-B1F5-CB8E4E19F16D @default.
- Q85300419 P2093 Q85300419-71B9BB7A-3AE5-40CE-B495-D3F481768B9A @default.
- Q85300419 P2093 Q85300419-937A3394-78C7-4825-89E8-BAF6C1FCC7E5 @default.
- Q85300419 P304 Q85300419-A23E95DC-D910-436D-A130-F3471DD714EC @default.
- Q85300419 P31 Q85300419-59AAEB1D-0B15-49A6-81D2-EADFAEC9FF80 @default.
- Q85300419 P356 Q85300419-41CE501A-D38A-45D8-A9B3-B9AC27202E37 @default.
- Q85300419 P433 Q85300419-4ED137A8-B8EE-4954-8E26-E21DF1103AA4 @default.
- Q85300419 P478 Q85300419-D71A596A-1516-4F6A-9662-6A012196157E @default.
- Q85300419 P577 Q85300419-DE6CF382-386A-406B-8419-DE512A38B656 @default.
- Q85300419 P698 Q85300419-BDD36D41-1CE9-4AFE-8BD5-4A4A1901091B @default.
- Q85300419 P921 Q85300419-71CB2A0B-755D-4BE4-A75B-E1C590F08F68 @default.
- Q85300419 P921 Q85300419-BA78E331-684C-4AB5-A4C3-12B49294BE7F @default.
- Q85300419 P356 IJSA.2012.012053 @default.
- Q85300419 P698 23104755 @default.
- Q85300419 P1433 Q15716692 @default.
- Q85300419 P1476 "Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary" @default.
- Q85300419 P2093 "C Bradbeer" @default.
- Q85300419 P2093 "M George" @default.
- Q85300419 P2093 "P Baker" @default.
- Q85300419 P2093 "S Ngwenya" @default.
- Q85300419 P304 "759" @default.
- Q85300419 P31 Q13442814 @default.
- Q85300419 P356 "10.1258/IJSA.2012.012053" @default.
- Q85300419 P433 "10" @default.
- Q85300419 P478 "23" @default.
- Q85300419 P577 "2012-10-01T00:00:00Z" @default.
- Q85300419 P698 "23104755" @default.
- Q85300419 P921 Q390475 @default.
- Q85300419 P921 Q423467 @default.